3 FTSE 100 and FTSE 250 value stocks I’d buy right now

The London Stock Exchange is packed with top value stocks offering low earnings multiples and big dividend yields. These three are on my shopping list.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Smiling family of four enjoying breakfast at sunrise while camping

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m searching the FTSE 100 and FTSE 250 for the best value stocks that money can buy. Here are three I’ll be looking to add to my portfolio when I have extra cash to invest.

GSK

Failure at the lab bench can play havoc with drugs developers’ profits. Yet a growing global population and rising healthcare spending in developing countries provide a wealth of opportunities for such businesses.

FTSE 100 share GSK (LSE:GSK) is one such on my radar. It has a phenomenal track record of getting its products past regulators and onto pharmacy shelves. And it’s investing heavily in fast-growing therapy areas like vaccines, oncology and respiratory to give earnings an additional boost.

The company’s sale of $804m worth of Haleon shares late last week gives GSK’s shares extra appeal, too. The extra funds give it additional financial firepower to invest in its product pipeline. They also give it more balance sheet strength to pay decent dividends to its shareholders.

Today GSK’s share price commands a forward price-to-earnings (P/E) ratio of 10 times. They also carry a healthy 3.8% prospective dividend yield, proving attractive all-round value.

NCC Group

IT services businesses like NCC Group (LSE:NCC) haven’t had the best of times more recently. This UK share — an expert in the field of cyber security — cut its profit forecasts just over a month ago chiefly due to trouble in North America.

Tech sector troubles have caused clients to cancel or delay buying decisions, the firm said, while further interest rate rises had also sapped customer appetite. The collapse of Silicon Valley Bank had damaged tech market confidence and thus project spending, too.

But I believe these troubles are baked into NCC’s low share price. For the year to May 2024 the FTSE 250 firm trades on a P/E ratio of just 8 times.

As a long-term investor I find its shares highly attractive at current prices. Fixing cyber attacks is an expensive business (outsourcing giant Capita recently said that a security breach could cost it £20m). And the threat from hackers is steadily growing as the world becomes increasingly digitalised. I expect NCC to recover strongly from its current troubles.

TBC Bank Group

I’ve long had my eye on TBC Bank Group (LSE:TBCG) shares. I feel the company’s leading position in Georgia’s fast-growing banking industry could deliver exceptional returns. And following this week’s sizzling market update I’m considering finally adding it to my portfolio.

Net interest income and pre-tax profit soared 27% and 19% respectively in the first quarter. This was driven by rapid growth in the Georgian economy (7.2% during the period) and a jump in customer numbers (up 42% year on year to 14.8m).

Okay, banks are highly cyclical and growth at TBC could stall if the global economy encounters a fresh crisis. Yet in my opinion the FTSE 250 firm’s low valuation still makes it a top-class value stock to buy.

Today it trades on a forward P/E ratio of 3.9 times. It also sports a terrific 8.2% prospective dividend yield.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended GSK and Haleon Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

3 ISA strategies to consider in 2025

This Fool believes that when it comes to building wealth through an ISA portfolio, there are three basic approaches worth…

Read more »

Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
Investing Articles

7 top tips to consider for an £88k passive income!

A regular monthly investment in trusts or shares could yield a stunning passive income in retirement. Here's how an investor…

Read more »

Stack of one pound coins falling over
Investing Articles

2 penny shares I think could shine in 2025

I have my eye on a few penny shares, as I'm thinking that the year ahead could turn out to…

Read more »

Investing Articles

2 ISA strategies for success in 2025

The ISA is a great vehicle for our investments, sheltering our returns from tax and providing us with the opportunity…

Read more »

Investing Articles

Here’s how an investor could start building a £10,000 second income for £180 per month in 2025

Our writer illustrates how an investor could put under £200 each month into shares and build a long-term five-figure passive…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Here’s how I’m finding bargain shares to buy for 2025!

Our writer takes a fairly simply approach when it comes to hunting for cheap shares to buy for his portfolio.…

Read more »

A graph made of neon tubes in a room
Investing Articles

Up 262%! This lesser-known energy company is putting other S&P 500 stocks to shame

Our writer delves into the rationale behind the parabolic growth of this under-the-radar S&P 500 energy company. The reason isn’t…

Read more »

Investing Articles

Just released: December’s small-cap stock recommendation [PREMIUM PICKS]

We believe the UK small-cap market offers a myriad of opportunities across a wide range of different businesses and industries.

Read more »